Clinical Trial Update: Clinical Study of Divozilimab in Patients With Systemic Scleroderma [Phase 3]

View source ↗

Summary

Biocad's Phase 3 clinical study of Divozilimab for systemic sclerosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Divozilimab (Divozilimab)

Snippet

Sponsor: Biocad | Conditions: Systemic Scleroderma | Phase 3 | Status: ACTIVE_NOT_RECRUITING